```html

Keratoma – Comprehensive Medical Guide

Overview

Keratoma (also called a corneal keratoma or skin keratoma, depending on location) is a benign, hyperkeratotic growth that arises from an over‑production of keratin in the epidermis or, in the eye, the corneal epithelium. The term is most frequently applied to two distinct clinical entities:

• Cutaneous keratoma – thickened, wart‑like lesions commonly found on the palms, soles, or areas of repeated friction.
• Corneal keratoma – a rare, localized thickening of the corneal stroma that can appear as a white, dome‑shaped nodule.

Because the skin and corneal forms share the underlying mechanism (excess keratin), the guide groups them together but highlights the differences where relevant.

Who it affects: Cutaneous keratomas are most common in middle‑aged to older adults (40‑70 years) and are slightly more prevalent in men. Corneal keratomas are extremely rare, with fewer than 200 cases reported worldwide, usually presenting in young adults (20‑40 years).

Prevalence:

• Plantar (sole) keratomas affect roughly 5–8 % of the general population, increasing to >20 % in people who stand or walk extensively for work (e.g., construction, retail).【source1】
• Corneal keratoma accounts for <0.01 % of all corneal stromal lesions.【source2】

Symptoms

Cutaneous keratoma

• Thick, raised nodule – usually 0.5–2 cm, hard to the touch.
• Rough surface – may resemble a callus or wart.
• Pain or tenderness – especially when pressure is applied (e.g., walking).
• Redness or inflammation around the base if the lesion becomes irritated.
• Cracking or fissuring of the overlying skin, leading to bleeding.
• Altered gait in severe foot keratomas due to discomfort.

Corneal keratoma

• White or grayish nodular opacity on the cornea, often central or paracentral.
• Blurred or reduced vision proportionate to size and location.
• Glare or halos around lights.
• Eye discomfort – mild burning, foreign‑body sensation.
• Redness (conjunctival injection) if secondary inflammation occurs.
• Dryness or tearing due to ocular surface irritation.

Causes and Risk Factors

Cutaneous keratoma

• Mechanical friction – repetitive pressure (e.g., walking barefoot, tight shoes).
• Genetic predisposition – families with a history of hyperkeratotic disorders.
• Age – keratin turnover slows, leading to accumulation.
• Occupational exposure – athletes, dancers, military personnel.
• Skin conditions – eczema or psoriasis can increase risk of secondary keratoma.

Corneal keratoma

• Congenital anomalies – developmental defects in stromal collagen organization.
• Trauma – penetrating or blunt injury that disrupts corneal epithelium.
• Chronic inflammation – untreated keratitis or granular dystrophy.
• UV exposure – cumulative sunlight damage may trigger abnormal keratinization in susceptible eyes.
• Genetic mutations – rare mutations in genes controlling corneal extracellular matrix (e.g., TGFBI).

Diagnosis

Clinical examination

Physicians begin with a detailed history and physical exam. For skin lesions, the clinician will:

• Inspect lesion size, borders, and surface texture.
• Palpate for firmness and tenderness.
• Assess gait and footwear for contributing factors.

For a suspected corneal keratoma, an ophthalmologist performs:

• Slit‑lamp biomicroscopy – magnified view of the cornea to document depth and opacity.
• Corneal topography – maps surface curvature to see if vision is affected.
• Anterior segment optical coherence tomography (AS‑OCT) – high‑resolution cross‑sectional imaging to measure thickness.

Laboratory and imaging tests

• Skin biopsy (if diagnosis is uncertain) – histopathology shows hyperkeratosis without atypia, ruling out squamous cell carcinoma.
• Dermatoscopy – non‑invasive visualization of surface patterns; helps differentiate keratoma from plantar warts.
• Confocal microscopy (ocular) – can assess cellular architecture of corneal lesions.

When to order additional work‑up

If there is rapid growth, ulceration, or atypical appearance, clinicians may order imaging (ultrasound biomicroscopy for cornea) or refer to dermatology/pathology to exclude malignancy.

Treatment Options

Conservative management

• Footwear modification – cushioned insoles, wide toe boxes, orthotics to reduce pressure.
• Keratin‑softening agents – topical salicylic acid (2 %) or urea cream (10‑20 %) applied nightly for 2‑4 weeks.
• Moisturization – petroleum‑jelly or lanolin to keep skin pliable.

Procedural treatments – Cutaneous keratoma

• Paring or debridement – sterile scalpel or curette to thin the lesion; often combined with keratolytic creams.
• Cryotherapy – liquid nitrogen applied for 10‑15 seconds; effective for smaller lesions.
• Electrodessication & curettage (EDC) – electrical current removes tissue and cauterizes bleeding.
• Laser therapy – CO₂ or Er:YAG laser precisely vaporizes excess keratin with minimal surrounding damage.
• Surgical excision – reserved for large, painful nodules or when malignancy cannot be excluded.

Procedural treatments – Corneal keratoma

• Phototherapeutic keratectomy (PTK) – excimer laser ablation to flatten the nodule and restore corneal regularity.
• Lamellar keratoplasty – partial‑thickness corneal transplant for deep or recurrent lesions.
• Topical anti‑inflammatory drops (e.g., prednisolone acetate 1 %) to control secondary inflammation.
• Contact lens protection – band‑age lenses shield the cornea while healing.

Medications

• Topical retinoids (tretinoin 0.025 %) – promote orderly keratinization; used off‑label for stubborn plantar keratomas.
• Systemic therapy – oral acitretin may be considered for extensive hyperkeratotic disease, but side‑effects limit routine use.

Lifestyle & self‑care

• Daily foot soaking in warm water (10‑15 min) followed by gentle exfoliation.
• Avoid walking barefoot on hard surfaces.
• Regular eye lubrication (artificial tears) for corneal keratoma patients.
• Protect eyes from UV with sunglasses that block ≥99 % UVA/UVB.

Living with Keratoma

Daily management tips – Skin

• Foot hygiene – wash with mild soap, dry thoroughly, especially between toes.
• Moisturize after bathing while skin is still damp.
• Rotate shoes every 2–3 days to allow airflow and prevent moisture buildup.
• Check for pressure points daily; use cushioned pads if needed.
• Monitor lesions for changes in size, color, or pain and keep a photo journal.

Daily management tips – Eye

• Apply preservative‑free artificial tears 4–6 times per day.
• Avoid eye rubbing; use a cool compress for discomfort.
• Wear protective eyewear during sports, gardening, or any activity with dust/small particles.
• Schedule regular follow‑ups (every 6‑12 months) with an ophthalmologist.

Psychosocial aspects

Visible keratomas, especially on the hands or feet, can affect self‑image. Support groups for chronic skin conditions and counseling can help patients cope with anxiety or embarrassment.

Prevention

• Footwear – choose shoes with adequate arch support and shock‑absorbing soles.
• Gradual activity increase – avoid sudden spikes in walking or running mileage.
• Skin moisturization – apply a thick emollient after showers at least twice daily.
• UV protection – wear wide‑brimmed hats and UV‑blocking sunglasses year‑round.
• Prompt treatment of minor injuries – keep cuts clean to prevent chronic irritation that can trigger keratin overgrowth.
• Regular self‑examination – early detection makes conservative treatment more effective.

Complications

• Secondary infection – fissured keratomas can become colonized with bacteria or fungi, leading to cellulitis or osteomyelitis in severe foot cases.
• Ulceration – pressure‑induced ulcers may develop, especially in diabetics or peripheral vascular disease patients.
• Altered gait and musculoskeletal pain – chronic discomfort can cause knee, hip, or back strain.
• Visual impairment – corneal keratoma that encroaches on the visual axis can cause permanent scarring if not treated.
• Misdiagnosis of malignancy – rare but important; untreated squamous cell carcinoma can masquerade as a keratoma.

When to Seek Emergency Care

---

Sources: 1. Mayo Clinic. “Plantar callus and corn treatment.” 2023.
2. National Eye Institute (NEI). “Corneal stromal lesions.” 2022.
3. Centers for Disease Control and Prevention (CDC). “Foot health in occupational settings.” 2021.
4. Cleveland Clinic. “Keratoma – causes and management.” 2023.
5. WHO. “UV radiation and eye disease.” 2020.

```